Bergua Burgués, Juan Miguel | Hematología y Hemoterapia |

Resultados: 183
Tipo Título / Nombre Autor(es) Año
Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3-ITD Mutation-Positive Acute Myeloid Leukemia Martínez-Cuadrón D, Serrano J, Mariz J, Gil C, Tormo M..., Bergua J 2022
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4 Kayser S, Martínez-Cuadrón D, Hanoun M, Stölzel F, Gil C..., Burgues JMB 2022
Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry Labrador J, Martínez-Cuadrón D, de la Fuente A, Rodríguez-Veiga R, Serrano J..., Bergua JM 2022
Validation of the Burkitt Lymphoma International Prognostic Index in patients treated with two prospective chemoimmunotherapy trials in Spain Ribera JM, García O, Buendía-Ureña B, Terol MJ, Vicent A..., Bergua J 2022
Biomarker-driven phase Ib clinical trial of OPB-111077 in acute myeloid leukemia Martínez López J, Montesinos P, López Muñoz N, Ayala R, Martínez Sánchez P..., Bergua Burgues JM 2022
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma Tilly H, Morschhauser F, Sehn LH, Friedberg JW, Trneny M..., Bergua-Burgués JM 2021
The POLARIX Study: Polatuzumab Vedotin with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma Morschhauser F, Sehn LH, Friedberg JW, Trneny S ..., Bergua Burgues JM 2021
Long-Term Subgroup Analyses from Azacitidine Vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the Pethema Registry Labrador J, Fuente A de la, Martínez-Cuadrón D, Rodríguez-Veiga R..., Bergua Burgues JM 2021
Patterns of Salvage Therapy in Patients with Acute Myeloid Leukemia Treated Upfront with Azacitidine or Decitabine: Results from the Pethema AML Registry Labrador J, Fuente A de la, Martínez-Cuadrón D, Rodríguez-Veiga R..., Bergua Burgues JM 2021
Integrated Multidimensional Flow Cytometry (MFC) and Next-Generation Sequencing (NGS) to Reconstruct Evolutionary Paterns from Dysplasia to Acute Myeloid Leukemia (AML) Simoes CP, Chillon C, Martínez -Cuadrón D, Calasanz JM..., Bergua Burgues JM 2021